AlphaMaven AlphaMaven

A Major Endowment Slashed the Value of Its Stake in Thrive Capital

Reported by Businessinsider
Feb 13, 2023· 2 min read
Save Post LinkedIn Email
Key Takeaways
  • • A major endowment has written down the value of its investment in Joshua Kushner's Thrive Capital, citing a 31% loss in the fund's value over the past year, according to disclosures reviewed by Business Insider.
  • • Thrive Capital, a $3 billion venture capital firm based in New York, has faced significant valuation pressure amid broader venture market headwinds and a pullback in startup funding during 2022.
  • • The write-down signals deteriorating performance at one of the venture industry's most prominent firms, which manages multiple funds and has backed major technology companies across software, internet, and AI sectors.
  • • This valuation adjustment reflects the challenging environment for venture capital returns, with limited partners (endowments, pension funds, and foundations) increasingly scrutinizing fund performance and marking down positions accordingly.
Summary
A major university or institutional endowment has marked down the value of its stake in Thrive Capital, the New York-based venture capital firm founded by Joshua Kushner, according to disclosures examined by Business Insider. The endowment recorded a 31% loss in the fund's value over the past year, signaling material deterioration in Thrive Capital's portfolio performance and valuation metrics.

Thrive Capital manages approximately $3 billion in assets and has positioned itself as a prominent player in venture capital, focusing on software and internet companies while increasingly moving into larger public company positions, including a disclosed $215 million stake in Amazon. The firm has raised substantial capital from limited partners, including the endowment now writing down its position, which initially backed Thrive Capital's launch with a $10 million investment in 2010 under the leadership of Princeton endowment head Andy Golden.

The endowment's decision to reduce the recorded value of its Thrive Capital stake reflects the broader contraction in venture capital valuations during 2022, a period marked by significant pullback in startup funding, reduced exit activity, and elevated mark-to-market pressure on existing positions. The 31% annual decline aligns with industry-wide challenges that have pressured venture fund performance across the sector, forcing institutional investors to reassess valuations using updated comparables and market conditions.

This write-down carries particular significance given Thrive Capital's status within the venture ecosystem and its track record of raising substantial capital commitments from sophisticated institutional investors. The valuation adjustment underscores the vulnerability of even well-established venture firms to market cycle shifts and serves as a data point for other limited partners evaluating their own venture capital exposures and performance reporting requirements.

Go deeper than the headline

Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.

Start your free 7-day trial

Sources

1 outlet

AlphaMaven summarised this story from the reporting below. Each link opens the original article.

Businessinsider A Major Endowment Slashed the Value of Its Stake in Thrive Capital